Navigation Links
Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress
Date:9/26/2011

maceuticals

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company's initial focus is on developing novel therapies for the underserved subpopulation of COPD patients not able to effectively control their disease with dry powder or metered dose inhalers.  Elevation's lead drug candidate is EP-101, an inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist bronchodilator, in Phase 2 studies for the improved treatment of patients with severe COPD.  Elevation is a privately held company headquartered in San Diego, California. For additional information, please visit www.elevationpharma.com

About eFlow® Technology and PARI Pharma

EP-101 is delivered by an investigational eFlow® Nebulizer System developed by PARI Pharma and optimized specifically for EP-101. The optimized, investigational eFlow Nebulizer System uses eFlow Technology to enable highly efficient aerosolization of medication including liquid formulations via a vibrating, perforated membrane that includes thousands of laser drilled holes. Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. eFlow® Technology is not an ultrasonic nebulizer technology, and it is not a general purpose electronic aerosol generator nebulizer technology. Combined with its quiet mode of operation, small size, light weight, and battery use, eFlow Technology reduces the burden of taking daily, inhaled treatments. PARI Pharma focuses on the development of aerosol delivery devices and comprehensive inhalation drug development to advance aerosol therapies where drug and device can be optimized together. For addition
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone
2. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study
3. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
8. Auxilium Pharmaceuticals to Present at the Morgan Stanley 2011 Healthcare Conference
9. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
10. Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
11. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the IncuCount ... they have expanded their colony counter product line to ... and ImpressCount. These affordable colony counters that range ... microbiology and pharmaceutical manufacturing. , The previously released IncuCount ... white enclosure with jet black accents represent the updated ...
(Date:5/21/2013)... Inflamax scientists worked closely with internationally ... the study, which will provide critical insight into ... in the study of allergy treatments, the Environmental ... models. Although both the models are well recognized ... direct comparison between the allergic responses evoked by ...
(Date:5/21/2013)... Boston, MA (PRWEB) May 21, 2013 Possible ... parents. And so, according to a report from eagletribune.com posted ... for mold. In case the result is positive, My Cleaning ... without using harmful chemical ingredients. , It was said in ... re-infestation in the campus sparked after a first-grade ...
(Date:5/21/2013)... WOBURN, MA (PRWEB) May 21, 2013 ... for rapid bacterial strain typing, announced today that it ... 250 pathogenic E. coli strains obtained from the Centers ... Genome Sequence Scanning™ (GSS™) technology. The findings are detailed ... Meeting of the American Society for Microbiology in Denver ...
Breaking Biology Technology:Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces today ... Cellectis, approaches on vectors for meganucleases and genome surgery at the 13th ... held at the Marriott Wardman Park Hotel in Washington, USA , ... , , ...
... ,, TAIZHOU, China , ... Ltd.,one of the world,s leading biotechnology companies focusing on ... China Medical City (CMC) opened, China,s state-of-the-art stem ... Stem Cell Regenerative Medicine Industrial Project of,National Bio-Industry Base ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), ... cancer, today announced the dosing of the first patient under the ... in prostate cancer patients. The study will evaluate the localization, safety, ...
Cached Biology Technology:Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 3Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 4Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 5Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 2Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 3
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... complex feat of nanoengineering, a team of scientists at ... in creating a programable molecular transport system, the workings ... results, appearing in the latest issue of Nature ... advanced drug delivery methods and molecular manufacturing systems. ...
... Pharmaceuticals, illicit drugs, shampoo, toothpaste, pesticides, chemical run-off ... giant aquifer under Mexico,s "Riviera Maya," research shows. ... water-filled caves under the popular tourist destination on ... through the caves and into the Caribbean Sea. ...
... the days of Darwin, the "tree of life" has been ... gradual branching and changing of individual species. The discovery ... directly from one species of fungus to another, however, significantly ... mosaic, may be more appropriate. "The fungi are telling ...
Cached Biology News:Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 2Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 3Discovery of jumping gene cluster tangles tree of life 2Discovery of jumping gene cluster tangles tree of life 3
... Detection Assay is an anchorage-independent growth assay ... most stringent assay for detecting malignant transformation ... (pre-treated with carcinogens or carcinogen inhibitors) are ... medium for 21-28 days. Following this ...
... EZ DNA Methylation Kit uses a simplified ... DNA methylation analysis. The kit is based ... place between cytosine and sodium bisulfite where ... DNA Methylation Kits innovative in-column desulphonation reaction ...
... standard is a lyophilized mixture of ... molecular weights range from 152 to ... use with the Aminex HPX-87C column ... column testing or semiquantitative determination. Supplied ...
... from KUBTEC is a dual capability system with ... representation of the specimen under test. While the ... images, the micro focus source also allows the ... standard 2D images. The 50 mm x 50 ...
Biology Products: